NCT01594983
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Novartis Investigative Site Muscle Shoals, Alabama, United States
- Novartis Investigative Site Glendale, Arizona, United States
- Novartis Investigative Site Encinitas, California, United States
- Novartis Investigative Site Colorado Springs, Colorado, United States